A phase II study of the combination of bevacizumab (rhuMAb VEGF, BV) and oxaliplatin (O), plus capecitabine (C) in patients (Pts) with advanced colorectal cancer (ACRC)

被引：0
|
作者：
Veri, A. [1 ]
Ravaioli, A. [2 ]
Oliviero, G. [2 ]
Sarmiento, R. [1 ]
Torino, F. [1 ]
Frustaci, S. [3 ]
Buonadonna, A. [3 ]
Mattioli, R.
Lippe, C. [4 ]
Gebbia, V. [5 ]
Agueli, R. [5 ]
Lonoce, V. A. [1 ]
Gasparini, G. [1 ]
机构：
[1] ACO San Filippo Neri, Rome, Italy
[2] Osped Infermi, Rimini, Italy
[3] Oncol Med CRO Aviano PD, Aviano, Italy
[4] Oncol Med Osped Santa Croce Fano PU, Aviano, Italy
[5] Casa Cura Alta Specialita La Maddalena SPA, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] PHASE II STUDY OF THE COMBINATION OF BEVACIZUMAB (RHUMAB VEGF) AND OXALIPLATIN PLUS CAPECITABINE (XELOX) IN PATIENTS WITH ADVANCED COLORECTAL CANCER
    Sarmiento, R.
    Frustaci, S.
    Torino, F.
    Ravaioli, A.
    Mattioli, R.
    Gebbia, V.
    Veri, A.
    Gasparini, G.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 144 - 144
  • [2] Phase II study of the combination of bevacizumab (Rhumab VEGF) and oxaliplatin plus capecitabine (Xelox) in patients with advanced colorectal cancer
    Sarmiento, R.
    Frustaci, S.
    Bonadonna, A.
    Ravaioli, A.
    Oliviero, G.
    Mattioli, R.
    Tarnburrano, T.
    Gebbia, V
    Agueli, R.
    Torino, F.
    Lo Noce, V
    Veri, A.
    Gasparini, G.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 85 - 86
  • [3] WEEKLY OXALIPLATIN AND CAPECITABINE CONTINUOUSLY IN ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER (ACRC). A PHASE II STUDY
    Pochettino, Paolo
    Bergnolo, Paola
    Boglione, Antonella
    Dal Canton, Orietta
    Cutin, Simona Chiado
    Garetto, Ferdinando
    Biscardi, Emanuela
    Comandone, Alessandro
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 61 - 61
  • [4] A phase ii study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer
    Bendell, J.
    Fernando, N.
    Morse, M.
    Blobe, G.
    Yu, D.
    Sutton, L.
    Vaccaro, G.
    Honeycutt, W.
    Franklin, A.
    Hurwitz, H.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 67 - 67
  • [5] Phase II study of oxaliplatin, capecitabine, and irinotecan (OCI) in patients (pts) with previously untreated advanced colorectal cancer
    Pavia, OA
    Cangiano, J
    Crisostomo, R
    Caceres, W
    Barranco, E
    Wright, M
    Antonia, T
    Antonia, S
    Sullivan, D
    Garrett, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 307S - 307S
  • [6] A phase II study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer.
    Bendell, J. C.
    Fernando, N.
    Morse, M.
    Blobe, G.
    Yu, D.
    Sutton, L.
    Schaffer, S.
    Honeycutt, W.
    Franklin, A.
    Hurwitz, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 156S - 156S
  • [7] Phase III study of 5-fluorouracil/leucovorin plus oxaliplatin versus capecitabine plus oxaliplatin as first line therapy in patients with advanced colorectal cancer (ACRC)
    Porschen, R
    Arkenau, T
    Kubicka, S
    Schmoll, HJ
    Seufferlein, T
    Graeven, U
    Grothey, A
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A438 - A438
  • [8] OXALIPLATIN AND CAPECITABINE (XELOX) PLUS BEVACIZUMAB (BEVA) FOR ELDERLY PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (mCRC): BOXE, A PHASE II TRIAL
    Rosati, Gerardo
    Cordio, Stefano
    Leo, Silvana
    Daniele, Bruno
    Butera, Alfredo
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v104 - v104
  • [9] Activity of the combination of bevacizumab (Bev) with capecitabine/irinotecan (CapIri/Bev) or capecitabine/oxaliplatin (CapOx/Bev) in advanced colorectal cancer (ACRC): A randomized phase II study of the AIO Colorectal Study Group (AIO trial 0604)
    Reinacher-Schick, A. C.
    Kubicka, S.
    Freier, W.
    Arnold, D.
    Dietrich, G.
    Geissler, M.
    Hegewisch-Becker, S.
    Graeven, U.
    Schmoll, H.
    Schmiegel, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Phase II trial of irinotecan and capecitabine in patients with advanced colorectal cancer (ACRC)
    Ahn, JB
    Jung, KH
    Park, YS
    Kim, YH
    Chang, HJ
    Sohn, DK
    Lim, SB
    Choi, HS
    Jeong, SY
    Park, JG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 299S - 299S
12345